Document is current
Any future updates will be listed below
-
Authors
Ross, Matthew O. https://orcid.org/0000-0003-2115-9806
Xie, Yuan https://orcid.org/0000-0001-5105-7136
Owyang, Ryan C. https://orcid.org/0000-0003-0532-5915
Ye, Chang https://orcid.org/0000-0003-0236-5671
Zbihley, Olivia N. P. https://orcid.org/0000-0003-1887-4112
Lyu, Ruitu https://orcid.org/0000-0003-4597-1604
Wu, Tong https://orcid.org/0000-0001-9968-9909
Wang, Pingluan
Karginova, Olga
Olopade, Olufunmilayo I. https://orcid.org/0000-0002-9936-1599
Zhao, Minglei https://orcid.org/0000-0001-5832-6060
He, Chuan https://orcid.org/0000-0003-4319-7424
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences (R01ES030546, K99ES034084)
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (HG006827)
U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences
University of Chicago Yen Postdoctoral Fellowship
Breast Cancer Research Foundation (FP049439)
- License Information
-
More Information
Article History
Received: 30 August 2023
Accepted: 10 July 2024
First Online: 13 August 2024
Change Date: 27 February 2025
Change Type: Update
Change Details: This article was originally published under a CC BY-NC-ND 4.0 license, but has now been made available under a Creative Commons Attribution 4.0 International License (
Change Details: https://creativecommons.org/licenses/by/4.0/
Change Details: ), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. license. The PDF and HTML versions of the paper have been modified accordingly.
Competing interests
: C.H. is a scientific founder and equity holder of Aferna Green, Ellis Bio, AccuraDX, and Accent Therapeutics, and a scientific advisory board member of Aferna Green, Element Biosciences, and Rona Therapeutics. T.W. is an equity holder of AccuraDX. The remaining authors declare no competing interests.
